MIMEDX GROUP, INC. (MDXG)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 50M 100M 150M Q3 '21: 63.1M Q4 '21: 50.8M Q1 '22: 58.9M Q2 '22: 66.9M Q3 '22: 67.7M Q4 '22: 74.4M Q1 '23: 71.7M Q2 '23: 81.3M Q3 '23: 81.7M Q4 '23: 86.8M Q1 '24: 84.7M Q2 '24: 87.2M Q3 '24: 84.1M Q4 '24: 92.9M Q1 '25: 88.2M Q2 '25: 98.6M Q3 '25: 113.7M Q4 '25: 118.1M Q1 '26: 59M Q2 '26: 64.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 35M 70M 105M Q3 '21: 52.9M Q4 '21: 43.7M Q1 '22: 49M Q2 '22: 55.1M Q3 '22: 55.5M Q4 '22: 60M Q1 '23: 59.3M Q2 '23: 67.7M Q3 '23: 66.9M Q4 '23: 73M Q1 '24: 71.7M Q2 '24: 72.4M Q3 '24: 68.7M Q4 '24: 76M Q1 '25: 71.6M Q2 '25: 79.9M Q3 '25: 95M Q4 '25: 99M Q1 '26: 41.6M Q2 '26: 44.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-24M -16M -8M 0 8M 16M 24M Q3 '21: -1.1M Q4 '21: 1.3M Q1 '22: -9.3M Q2 '22: -9.6M Q3 '22: -7.1M Q4 '22: 11.3M Q1 '23: -340K Q2 '23: 10.8M Q3 '23: 11.1M Q4 '23: 15.5M Q1 '24: 13.2M Q2 '24: 23.4M Q3 '24: 11.2M Q4 '24: 11.1M Q1 '25: 8.3M Q2 '25: 12.4M Q3 '25: 22.2M Q4 '25: 21.1M Q1 '26: -16M Q2 '26: -18.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-20M 0 20M 40M 60M Q3 '21: -2.3M Q4 '21: 618K Q1 '22: -10.5M Q2 '22: -10.9M Q3 '22: -8.4M Q4 '22: -414K Q1 '23: -5M Q2 '23: 1.2M Q3 '23: 8.5M Q4 '23: 53.5M Q1 '24: 9.3M Q2 '24: 17.6M Q3 '24: 8.1M Q4 '24: 7.4M Q1 '25: 7M Q2 '25: 9.6M Q3 '25: 16.7M Q4 '25: 15.2M Q1 '26: -10.9M Q2 '26: -14.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 7M 14M 21M Q3 '21: 10.1M Q4 '21: 7.1M Q1 '22: 9.9M Q2 '22: 11.8M Q3 '22: 12.2M Q4 '22: 14.4M Q1 '23: 12.4M Q2 '23: 13.6M Q3 '23: 14.8M Q4 '23: 13.8M Q1 '24: 13M Q2 '24: 14.9M Q3 '24: 15.3M Q4 '24: 16.9M Q1 '25: 16.6M Q2 '25: 18.7M Q3 '25: 18.7M Q4 '25: 19.1M Q1 '26: 17.4M Q2 '26: 20M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-20M -10M 0 10M 20M 30M Q3 '21: 6.3M Q4 '21: -3.2M Q1 '22: -10.2M Q2 '22: -3M Q3 '22: 959K Q4 '22: -5.6M Q1 '23: -4M Q2 '23: 7.8M Q3 '23: 12.8M Q4 '23: 10.3M Q1 '24: 6M Q2 '24: 21.8M Q3 '24: 19.6M Q4 '24: 18.8M Q1 '25: 5.3M Q2 '25: 14.4M Q3 '25: 29.3M Q4 '25: 25M Q1 '26: 1.9M Q2 '26: -10M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-16M -8M 0 8M 16M 24M Q1 '21: -8.6M Q2 '21: 1.2M Q3 '21: 5.8M Q4 '21: -3.6M Q1 '22: -10.3M Q2 '22: -3.4M Q3 '22: 610K Q4 '22: -6.3M Q1 '23: -4.7M Q2 '23: 7.5M Q3 '23: 12.2M Q4 '23: 9.8M Q1 '24: 978K Q2 '24: 21.4M Q3 '24: 19.6M Q1 '21 Q3 '21 Q1 '22 Q3 '22 Q1 '23 Q3 '23 Q1 '24 Q3 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 60M 120M 180M Q1 '20: 107.5M Q2 '20: 108.1M Q3 '20: 108.5M Q1 '21: 109.4M Q2 '21: 110.3M Q3 '21: 110.7M Q1 '22: 111.6M Q2 '22: 112.9M Q3 '22: 113.4M Q1 '23: 114.4M Q2 '23: 146.9M Q3 '23: 149.8M Q1 '24: 150M Q2 '24: 148.9M Q3 '24: 148.4M Q1 '25: 149.7M Q2 '25: 149.3M Q3 '25: 149.7M Q1 '26: 148.4M Q2 '26: 147.8M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.50 -0.25 0.00 0.25 0.50 0.75 Q3 '21: -0.33 Q4 '21: -0.16 Q1 '22: -0.18 Q2 '22: -0.26 Q3 '22: -0.31 Q4 '22: -0.33 Q1 '23: -0.28 Q2 '23: -0.16 Q3 '23: -0.01 Q4 '23: 0.38 Q1 '24: 0.50 Q2 '24: 0.61 Q3 '24: 0.60 Q4 '24: 0.28 Q1 '25: 0.27 Q2 '25: 0.21 Q3 '25: 0.27 Q4 '25: 0.32 Q1 '26: 0.20 Q2 '26: 0.04 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.